Advertisement

The Italian Journal of Neurological Sciences

, Volume 11, Issue 1, pp 77–77 | Cite as

Side effects of low-dose cyclosporin A in the treatment of multiple sclerosis

  • Bramanti P. 
  • Leo M. Di 
  • Ricci R. M. 
  • Luca G. P. De 
  • Bella P. Di 
  • Rifici C. 
Letters

Keywords

Public Health Multiple Sclerosis Cyclosporin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. [1]
    Bailey R.R. et al.:Renal transplant recipients immunosuppressed with Sandimmun (CYA): 3 side effects possibly attributable to CYA. N.Z. med. J., 98,915–916, 1985.PubMedGoogle Scholar
  2. [2]
    Ballantyne C.M. et al.Hyperlipidemia following heart transplantation Transplant. Rev. 65:5, 1982Google Scholar
  3. [3]
    Britton S., Palacios R.:Cyclosporin A: Usefulness, risks and mechanisms of action. Immunol. Rev. 65:5, 1982.PubMedGoogle Scholar
  4. [4]
    Kappos L., Patzold U.:Cyclosporine versus Azathioprine in the long-term treatment of Multiple Sclerosis. Results of the German Multicenter study Ann. Neurol. 23:56–63, 1988.CrossRefPubMedGoogle Scholar
  5. [5]
    Michel F., Baguet J.C., Grapin C.H. et al.:Bone marrow toxicity of Sandimmun (CYA)? A case report Lancet II, 394, 1986.Google Scholar

Copyright information

© Masson Italia Periodici S.r.l. 1990

Authors and Affiliations

  • Bramanti P. 
    • 1
  • Leo M. Di 
    • 1
  • Ricci R. M. 
    • 1
  • Luca G. P. De 
    • 1
  • Bella P. Di 
    • 1
  • Rifici C. 
    • 1
  1. 1.Cattedra di NeurofisiopatologiaUniversità di MessinaMessinaItaly

Personalised recommendations